Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-26 @ 3:01 AM
Study NCT ID:
NCT04640402
Status:
COMPLETED
Last Update Posted:
2022-06-01
First Post:
2020-11-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)
Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-19
First Submit QC Date:
None
Study First Post Date:
2020-11-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-31
Last Update Post Date:
2022-06-01
Last Update Post Date Type:
ACTUAL